Libya vs Switzerland: Cases started on MDR-TB treatment
Libya
13
in 2023
Switzerland
12
in 2024
Libya rank
113th
Switzerland rank
116th
Cases started on MDR-TB treatment over time
- Libya
- Switzerland
How they compare
Libya currently reports 13 against 12 in Switzerland, a difference of 1.
That makes Libya's figure about 1.1 times Switzerland's.
The two have swapped places 1 time across 8 shared years of data; in 2011 it was Switzerland ahead.
Libya ranks 113th and Switzerland ranks 116th of 193 countries.
Across the 2 decades both report, Libya averaged higher in 1 and Switzerland in 1.
Head to head by decade
| Decade | Libya | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.25 | 10.5 | 9.25 | Switzerland |
| 2020s | 13.25 | 5 | 8.25 | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Libya or Switzerland?
- Libya, at 13 against 12 in Switzerland as of 2023.
- What is the difference in cases started on mdr-tb treatment between Libya and Switzerland?
- 1, with Libya ahead.
- How many years of comparable data are there for Libya and Switzerland?
- 8 years are reported by both, from 2011 to 2023.
- How do Libya and Switzerland rank globally for cases started on mdr-tb treatment?
- Libya ranks 113th and Switzerland ranks 116th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.